CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Adcock Ingram Holdings Limited Company Snapshot
Adcock Ingram Holdings Limited is a healthcare company. The Company is a pharmaceutical manufacturer, which manufactures, markets and distributes a range of healthcare products, and supplies to both the private and public sectors of the market. The Company's segments include Over the Counter (OTC), Consumer, Prescription and Hospital. The OTC segment focuses primarily on brands sold predominantly in the pharmacy market. The Consumer segment is engaged in the fast moving consumer goods (FMCG) space. The Prescription segment markets products prescribed by medical practitioners. The Hospital segment operates as a supplier of hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. The Company's products include Allergex Non-Drowsy, Panado Paed Syrups, Probiflora Infant, Cepacol, Medi-Keel A, Adco-Acyclovir Topical Cream and Adco-Normospor Vaginal Cream.

Sales Analysis. During the year ended June of 2020, sales at Adcock Ingram Holdings Limited were 7.35 billion South African Rands (US$483.18 million). This is an increase of 3.8% versus 2019, when the company's sales were 7.08 billion South African Rands. This was the fifth consecutive year of sales increases at Adcock Ingram Holdings Limited (and since 2015, sales have increased a total of 33%). Sales of Consumer saw an increase that was more than double the company's growth rate: sales were up 13.4% in 2020, from 786.90 million South African Rands to 892.39 million South African Rands. Adcock Ingram Holdings Limited also saw significant increases in sales in Hospital Products (up 11.9% to 1.63 billion South African Rands) . Not all segments of Adcock Ingram Holdings Limited experienced an increase in sales in 2020: sales of Other - Shared Services fell 80.4% to 12.95 million South African Rands. (However, this segment's sales were only a very small portion of the company's overall sales). Adcock Ingram Holdings Limited also experienced decreases in sales in Corporate (down 23.1% to 37.22 million South African Rands) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Adcock Ingram Holdings Limited
  Stock Performance Chart for Adcock Ingram Holdings Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 44.00
(Figures in South African Rands)
1 Week 0.5%   13 Weeks 8.6%  
4 Weeks 1.6%   52 Weeks -23.1%  
 
Adcock Ingram Holdings Limited Key Data:
  Ticker: AIP Country: South Africa
  Exchanges: JNB Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2020 Sales 7,346,558,000
(Year Ending Jan 2021).
Employees: 2,388
  Currency: South African Rands Market Cap: 7,733,389,884
  Fiscal Yr Ends: June Shares Outstanding: 175,758,861
  Share Type: Ordinary Closely Held Shares: 154,478,464
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.